• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theratechnologies Inc

+ Add to Watchlist

TH:CN

0.3900 CAD 0.0350 8.24%

As of 15:38:56 ET on 12/17/2014.

Snapshot for Theratechnologies Inc (TH)

Open: 0.4200 Day's Range: 0.3650 - 0.4250 Volume: 58,800
Previous Close: 0.4250 52wk Range: 0.3250 - 0.6500 1-Yr Rtn: -18.75%

Stock Chart for TH

No chart data available.
  • TH:CN 0.3900
  • 1D
  • 1M
  • 1Y
0.4250
Interactive TH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TH

Current P/E Ratio (ttm) -
Estimated P/E(11/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.1400
Est. EPS (CAD) (11/2014) -0.2050
Est. PEG Ratio -
Market Cap (M CAD) 23.79
Shares Outstanding (M) 61.01
30 Day Average Volume 69,850
Price/Book (mrq) 2.0716
Price/Sale (ttm) 4.4768
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TH

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for TH

Theratechnologies, Inc. is a specialty pharmaceutical company that discovers and develops therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. The Company's main product is being marketed in the United States for the reduction of excess abdominal fat n HIV-infected patients with lipodystrophy.

Luc TanguayPres/CEO/Investor RelationsLyne FortinSenior VP/Chief Commercial Ofcr
Christian MarsolaisSenior VP:Scientific AffairsMarie-Noel ColussiVP:Finance
More Company Profile & Key Executives for TH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil